-
A systematic approach to subgroup analyses in a smoking cessation trial.
Westover AN, Kashner TM, Winhusen TJ, Golden RM, Nakonezny PA, Adinoff B, Henley SS. A systematic approach to subgroup analyses in a smoking cessation trial. American Journal of Drug and Alcohol Abuse 2015;41(6):498-507.
-
Opioid addicted buprenorphine injectors: Drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia.
Piralishvili G, Otiashvili D, Sikharulidze Z, Kamkamidze G, Poole SA, Woody GE. Opioid addicted buprenorphine injectors: Drug use during and after 12-weeks of buprenorphine-naloxone or methadone in the Republic of Georgia. Journal of Substance Abuse Treatment 2015;50:32-37.
-
Depressive symptoms and associated clinical characteristics in outpatients seeking community-based treatment for alcohol and drug problems.
Sanchez K, Walker NR, Campbell ANC, Greer TL, Hu M, Grannemann BD, Nunes EV, Trivedi MH. Depressive symptoms and associated clinical characteristics in outpatients seeking community-based treatment for alcohol and drug problems. Substance Abuse 2015;36(3):297-303
-
Pathways to change: Use trajectories following trauma-informed treatment of women with co-occurring post-traumatic stress disorder and substance use disorders.
Lopez-Castro T, Hu M, Papini S, Ruglass LM, Hien DA. Pathways to change: Use trajectories following trauma-informed treatment of women with co-occurring post-traumatic stress disorder and substance use disorders. Drug and Alcohol Review 2015;34(3):242-251.
-
Risk factors associated with HCV among opioid-dependent patients in a multisite study.
Schulte MT, Hser Y, Saxon AJ, Evans E, Li L, Huang D, Hillhouse MP, Thomas C, Ling W. Risk factors associated with HCV among opioid-dependent patients in a multisite study. Journal of Community Health 2015;40(5):940-947.
-
Maximizing effectiveness trials in PTSD and SUD through secondary analysis: Benefits and limitations using the National Institute on Drug Abuse Clinical Trials Network “Women and Trauma” study as a case example.
Hien DA, Campbell ANC, Ruglass LM, Saavedra LM, Matthews AG, Kiriakos G, Morgan-Lopez AA. Maximizing effectiveness trials in PTSD and SUD through secondary analysis: Benefits and limitations using the National Institute on Drug Abuse Clinical Trials Network "Women and Trauma" study as a case example. Journal of Substance Abuse Treatment 2015;56:23-33.
-
Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003.
Barbosa-Leiker C, McPherson S, Mamey MR, Burns GL, Layton ME, Roll JM, Ling W. Examining the factor structure of the Clinical Opiate Withdrawal Scale: A secondary data analysis from the National Drug Abuse Treatment Clinical Trials Network (CTN) 0003. Drug and Alcohol Dependence 2015;152:218-222.
-
Self-report after randomly assigned supervision does not predict ability to practice motivational interviewing.
Wain RM, Kutner BA, Smith JL, Carpenter KM, Hu M, Amrhein PC, Nunes EV. Self-report after randomly assigned supervision does not predict ability to practice motivational interviewing. Journal of Substance Abuse Treatment 2015;57:96-101.
-
The effects of brief strategic family therapy (BSFT) on parent substance use and the association between parent and adolescent substance use.
Horigian VE, Feaster DJ, Brincks AM, Robbins MS, Perez MA, Szapocznik J. The effects of brief strategic family therapy (BSFT) on parent substance use and the association between parent and adolescent substance use. Addictive Behaviors 2015;42:44-50.
-
PrEP in substance abuse treatment: A qualitative study of treatment provider perspectives.
Spector AY, Remien RH, Tross S. PrEP in substance abuse treatment: A qualitative study of treatment provider perspectives. Substance Abuse Treatment, Prevention, and Policy 2015;10:1.